Skip to main content

Trelegy Ellipta: Uses, How It Works, and Common Side Effects

Trelegy ellipta (fluticasone, umeclidinium, vilanterol) is used to treat COPD including bronchitis and emphysema, and it is also used as a maintenance treatment for asthma in adults.

Video transcript

Trelegy ellipta (fluticasone, umeclidinium, vilanterol) is used to treat COPD including bronchitis and emphysema, and it is also used as a maintenance treatment for asthma in adults.

The inhaler contains a combination of 3 medicines fluticasone, umeclidinium, and vilanterol.

Fluticasone is a steroid that prevents the release of substances in the body that cause inflammation. Umeclidinium is an anticholinergic. Vilanterol is a long-acting bronchodilator.

These medications work by relaxing muscles in the airways to improve breathing.

This inhaler is not for use in treating an asthma attack or bronchospasm attack.

Vilanterol, when used alone, may increase the risk of death in people with asthma. However, this risk is not increased when vilanterol is used in a combination product with fluticasone and umeclidinium.

Common side effects may include cold or flu symptoms such as runny or stuffy nose, sore throat, cough, chest tightness, a lung infection, nausea, vomiting, constipation, diarrhea, joint pain, headache, back pain, mouth sores, hoarse voice, mouth pain, changes in your sense of taste.

This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Always consult with your healthcare provider.

Recommended videos

Ibuprofen: Pain Mechanism, Dose Safety and Drug Interactions

A brief discussion of mechanism of action, maximum doses and drug interactions for ibuprofen

Bridge with fitness ball

You can do many core exercises with a fitness ball. See the bridge.

Reverse crunch with fitness ball

You can do many core exercises with a fitness ball. See the reverse crunch.

How to use a dry powder disk inhaler

Watch this video to learn how to use a dry powder disk inhaler.

Macular degeneration

This animation shows the process of macular degeneration in the eye. The macula is the part of the retina that distinguishes fine details at the center of the field of vision. Macular degeneration results from a partial breakdown of the insulating layer between the retina and the choroid layer of blood vessels behind the retina. Macular degeneration results in the loss of central vision only.

Browse by category

By medication